ERIN CASEY: Open Payments
NPI 1386254753 · REPUBLIC, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,358 in 81 payments from 17 companies in 2025. Trend: 2023 $42 · 2024 $1,601 · 2025 $1,358
Food & beverage: $1,358
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $315 |
| ABBVIE INC. | 19 | $217 |
| Novo Nordisk Inc | 11 | $193 |
| Lilly USA, LLC | 6 | $113 |
| PFIZER INC. | 6 | $107 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $56 |
| Axsome Therapeutics, Inc. | 2 | $55 |
| Otsuka America Pharmaceutical, Inc. | 3 | $46 |
| Exact Sciences Corporation | 3 | $44 |
| Lundbeck LLC | 2 | $41 |
Products named: BREZTRI, QULIPTA, MOUNJARO, Ozempic, UBRELVY, REXULTI, Wegovy, PREVNAR 20.
Industry payments across MO — which companies pay providers there.
